NEWS

Jan. 14, 2019 - The XTC 2019 Top 3 Finalists are ActiveProtective (Philadelphia, Pennsylvania), developing a wearable that protects the hips of older adults using wearable airbags, Elevian (Boston, Massachusetts), creating regenerative medicines, with the potential to treat and prevent many age-related diseases and Lynq (Brooklyn, New York), the the world’s most advanced long-range tracker.

Jan. 11, 2019 - The collaboration is aimed at developing oral medications targeting the GDF11, or growth differentiation factor 11, pathway and associated targets — a concept that Elevian has been working on since inception.

Sept. 10, 2018 - Startup Elevian has raised millions to investigate whether a specific protein in young blood can have rejuvenating effects, despite disagreements over whether the science behind the idea is sound.

Sept. 10, 2018 - Elevian is developing medicines that restore the body's regenerative capacity, with the potential to treat and prevent age-related diseases. Elevian’s founders, working at Stanford and Harvard, discovered that young blood stimulates regeneration of many tissues and organs in old animals.

Sept. 6, 2018 - Today, the latest young-blood medicine-maker, Elevian, emerged from stealth with $5.5 million from investors including Peter Diamandis, one of the more prominent faces in the Silicon Valley “death disruption” scene. Beneath all the hype is some striking science.

Sept. 6, 2018 - A series of eye-catching papers on parabiosis experiments in mice, which identified a circulating protein that reverses aging-related tissue degeneration, has led to the formation of a new Harvard University spin-out, Elevian Inc., which has just closed a seed round of $5.5 million.

Sept. 6, 2018 - A company co-founded by former physician Mark Allen and several Harvard researchers are trying to develop a therapeutic to address aging to treat diseases like heart failure, coronary artery disease, and muscular dysfunction.

Sept. 5, 2018 - Age is the No. 1 risk factor behind most diseases in the developed world, according to numerous studies. That’s why Elevian, led by a team of Harvard researchers, is working to develop medicine that treats aging by restoring the body’s regenerative capacities.

May 4, 2014 -After combining the blood circulations of two mice by conjoining them — one old, the other young — researchers found dramatic improvements in the older mouse’s muscle and brain. After four weeks, stem cells in both those areas got a boost of activity and were better able to produce neurons and muscle tissue.